Corporate crime in the pharmaceutical industry
著者
書誌事項
Corporate crime in the pharmaceutical industry
（Routledge revivals）
Routledge, 2013, c1984
- : hbk
大学図書館所蔵 件 / 全1件
-
該当する所蔵館はありません
- すべての絞り込み条件を解除する
注記
Reprint. Originally published: London : Routledge & Kegan Paul, 1984
Includes bibliographical references (p. 408-427) and index
内容説明・目次
内容説明
First published in 1984, this book examines corporate crime in the pharmaceutical industry. Based on extensive research, including interviews with 131 senior executives of pharmaceutical companies in the United States, the United Kingdom, Australia, Mexico and Guatemala, the book is a major study of white-collar crime. Written in the 1980s, it covers topics such as international bribery and corruption, fraud in the testing of drugs and criminal negligence in the unsafe manufacturing of drugs. The author considers the implications of his findings for a range of strategies to control corporate crime, nationally and internationally.
目次
- Preface 1. Introduction: an industry case study of corporate crime 2. Bribery 3. Safety testing of drugs: from negligence to fraud 4. Unsafe manufacturing practices 5. Antitrust 6. The corporation as pusher 7. Drug companies and the Third World 8. Fiddling 9. Strategies for controlling corporate crime
- Appendix: Getting interviews with corporate executives
- Notes
- Bibliography
- Index
「Nielsen BookData」 より